MD Anderson Brain and Spine
Dr. Waldemar Priebe is a medicinal chemist with an interest in brain tumors, and a drug he discovered and developed is on its way to a clinical trial at MD…
Two studies by TGen and UNC Lineberger help shed light on aggressive brain cancer
Two studies by researchers at the Translational Genomics Research Institute (TGen) and the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) provide insight on the evolution of glioblastoma…
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Cancers evolve in rapidly changing environments from single cells into genetically heterogeneous masses. Darwinian evolution selects for survival of the fittest cells, that is, those that are best suited to…
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
High-grade gliomas are aggressive cancers that often become rapidly fatal. Immunotherapy using CD8+ cytotoxic T lymphocytes (CTLs), engineered to express both herpes simplex virus type 1 thymidine kinase (HSV1-TK) and…
St. Vincent de Paul: Culturally-grounded Diabetes Prevention Program
Obesity and type 2 diabetes (T2D) represent some of the most significant public health challenges facing our society. Disparities in obesity and T2D emerge early in life and disproportionately impact…
T-Gen/Mayo
The survival of patients diagnosed with glioblastoma (GBM), the most deadly form of brain cancer, is compromised by the proclivity for local invasion into the surrounding normal brain, which prevents…
Nicholas Butowski, M.D., Selected to Direct Brain Tumor Research at UCSF
Research is funded by Ivy Foundation Scottsdale, Ariz. (Dec. 9, 2015) – Nicholas Butowski, M.D., has been selected to serve as the principal investigator of the Ivy Foundation Early Phase…
TGen identifies drug that could limit the spread of deadly brain tumors
Study funded by Ivy Foundation shows PPF could help treat glioblastomas by sensitizing tumors to chemotherapy and radiation treatments PHOENIX, Ariz. — Nov. 12, 2015 — In a significant breakthrough,…
The Ben and Catherine Ivy Foundation Funds Extension of Mayo Clinic Brain Cancer Study with $1.3 Million
The Ben & Catherine Ivy Foundation (Ivy Foundation) announced an extension and funding of an additional $1.3 million for Mayo Clinic to study brain tumor vaccines that combine a patient’s…
Ivy GAP
Robust new data added to the Ivy Glioblastoma Atlas Project (Ivy GAP) changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for…